Ozelle GmbH

Founded in 2014, Ozelle is a German-based innovator in hematology diagnostics, driven by a mission to revolutionize blood cell analysis through cutting-edge technology. Our team, composed of postdoctoral researchers and scientists from leading U.S. universities and institutions, has pioneered a breakthrough in cell morphology—setting a new global standard for precision in medical diagnostics. Innovative Technology for Global Health At the heart of Ozelle’s success is our fully automated *manual* microscopic blood cell analyzer, a unique IVD (In Vitro Diagnostics) medical device that integrates advanced machine vision and artificial intelligence. By harnessing the power of cell morphology, our solution delivers unmatched accuracy, speed, and reliability, enabling healthcare professionals to diagnose with confidence. This technology not only streamlines workflows but also bridges the gap between traditional microscopy and modern automation, ensuring consistent results for over 50,000 medical institutions worldwide. We have more than 500 employees worldwide, at least 60% of whom are R&D personnel from our three R&D centers. Global Impact, Local Commitment From bustling urban hospitals to remote clinics, Ozelle’s systems empower healthcare providers across six continents. Our diverse, passionate team—united by a shared vision of equitable healthcare—works tirelessly to enhance diagnostic efficiency and accessibility. By transforming traditional methods, we aim to democratize high-quality medical services, ensuring every patient receives timely and precise care, no matter their location. Shaping Tomorrow’s Diagnostics Ozelle remains dedicated to pushing the boundaries of innovation. We continue to invest in AI-driven solutions and collaborative partnerships, striving to redefine global standards in diagnostics. Together, we’re not just analyzing blood cells—we’re building a healthier future for all.